Cancer cell movement during metastasis is a dynamic process regulated by several different signals. However, the way cells ...

Cancer cell movement during metastasis is a dynamic process regulated by several different signals. However, the way cells ...

Although immunotherapy is among the most significant advances in cancer care, it is not effective in all patients. University of Helsinki researchers have provided new insights into why some breast ...

Conquer Cancer®, the ASCO Foundation, presented the 2025 Young Investigator Awards (YIAs) funded by Vaniam Grouptm and Women Leaders in Oncology® (WLO). These prestigious awards celebrate and support ...

CHICAGO >> Treating breast cancer patients with AstraZeneca’s experimental pill camizestrant at the first sign of resistance ...

A Finnish discovery opens the door to more personalised cancer care. The research model is attracting global interest. The image shows a patient's ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

AstraZenecas experimental pill camizestrant significantly reduced the risk of disease progression or death in hormone ...

Actym Therapeutics has strengthened its IP portfolio with two newly issued patents covering its novel STACT™ biological ...

Treating breast cancer patients with AstraZeneca’s experimental pill camizestrant at the first sign of resistance to standard treatments cut the risk of disease progression or death by half, a finding ...

BeOne Medicines Ltd. , a global oncology company, announced new clinical data from its emerging breast cancer pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.